Latest News

A 45-year grant led to genomic sequencing of the SV40 virus and other key findings about viruses that cause cancer…

Machine learning algorithms accelerate biomedical research in viral infection, cardiovascular disease, breast cancer and more at Yale’s van Dijk Lab.

Connecticut Magazine has named 87 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2022 Best Doctors guide.

The Federation of American Societies for Experimental Biology (FASEB) today announced the recipients of its 2021 Excellence in Science Awards.

Greco hopes to advance the transformative work already being done in the stem cell field while also helping the society scrutinize the processes that both consciously and unconsciously contribute to an inequitable system.

Following an analysis of over 12,000 human genes, research from Yale Cancer Center indicates there is cancer-relevant importance in a much larger proportion of human genes than current cancer research models suggest. Much of cancer biology research focuses on a few dozen well studied genes called “cancer driver genes.” The new findings demonstrate that a larger number of genes are connected to cancer driver genes and may have an impact on cancer biology. The findings were published in the Journal of the National Cancer Institute.

Yale researchers have identified specific genes within T-cells that can be amplified to increase a T-cell’s ability to identify and kill cancer cells.

Six years after laying out an ambitious blueprint for the Yale Cancer Biology Institute, much of it has been realized by recruiting scientists with unlimited potential and offering them their first labs. Led by Mark Lemmon, PhD, FRS, the institute has been built around young scientists he calls “superstars.”

Dr. Muzumdar cares for patients with pancreatic cancer and explains how the Yale Pancreatic Cancer Collaborative is working together to search for novel combinations of chemotherapies and targeted therapies to further improve the treatment outcomes for pancreatic cancer.